Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1974 Jul;10(1):102–106. doi: 10.1128/iai.10.1.102-106.1974

Reactivity of Envelope, Capsid, and Soluble Antigens of Herpesvirus hominis Types 1 and 2 in the Indirect Hemagglutination Test

Arthur F Back 1, Nathalie J Schmidt 1
PMCID: PMC414963  PMID: 4366916

Abstract

Envelope, capsid, and soluble antigens of Herpesvirus hominis (HVH) types 1 and 2 were compared to crude antigens (disrupted HVH-infected cells) for potency, type-specificity, and diagnostic value in the indirect hemagglutination (IHA) test. The envelope appeared to be the predominant component reacting in the IHA test, but recurrent HVH infections increased the reactivity of human sera with capsid antigens. The soluble antigens reacted in the IHA test with HVH immune animal sera, but very few convalescent-phase human sera showed reactivity with soluble antigens. Overall, none of the subunit antigens showed greater type-specificity than did crude antigens in IHA tests with immune animal or convalescent-phase human sera. Recurrent infections with type 1 or type 2 viruses tended to broaden heterotypic reactivity of the patients' sera with both crude and subunit antigens, even in patients showing only a single type of antibody by IHA inhibition. Subunit antigens were no more sensitive than crude antigens in demonstrating significant IHA antibody titer rises for serodiagnosis of herpesvirus infections, and they generally had to be used at lower working dilutions than crude antigens.

Full text

PDF
102

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein M. T., Stewart J. A. Method for typing antisera to Herpesvirus hominis by indirect hemagglutination inhibition. Appl Microbiol. 1971 Apr;21(4):680–684. doi: 10.1128/am.21.4.680-684.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Feorino P. M., Palmer E. L. Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls. J Infect Dis. 1973 Jun;127(6):732–735. doi: 10.1093/infdis/127.6.732. [DOI] [PubMed] [Google Scholar]
  3. Martin M. L., Palmer E. L., Kissling R. E. Complement-fixing antigens of herpes simplex virus types 1 and 2: reactivity of capsid, envelope, and soluble antigens. Infect Immun. 1972 Feb;5(2):248–254. doi: 10.1128/iai.5.2.248-254.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES